DyeVert™ PLUS Contrast Reduction System is a dye management solution for patients with at-risk kidney factors, including:
1 Desch, S. et all. Impact of a novel contrast reduction system on contrast savings in coronary angiography – The DyeVert randomized controlled trial. Int J Cardiol (2018) https://doi.org/10.1016/j.ijcard.2017.12.107
Indications, contraindications, warnings, and instructions for use can be found in the product labeling supplied with each device. Risks may include air emboli and infection.
CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician.
Uncompromised Imaging: Seeing is Believing
Injections into coronary arteries may result in excess reflux into the aorta that is not needed for imaging. DyeVert™ PLUS reduces contrast amount without compromising image quality. See for yourself.